CC
ELV icon

Cedar Capital’s Elevance Health ELV Stock Holding History

Cedar Capital’s Portfolio ELV Stock Details ELV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-4,947
Closed -$1.33M – 98
2020
Q3 		$1.33M Buy
4,947
+1,378
+39% +$371K 0.44% 75
2020
Q2 		$939K Buy
3,569
+363
+11% +$96.8K 0.36% 80
2020
Q1 		$728K Buy
3,206
+20
+0.6% +$5.45K 0.34% 81
2019
Q4 		$962K Buy
3,186
+224
+8% +$61.6K 0.44% 75
2019
Q3 		$711K Buy
2,962
+996
+51% +$273K 0.33% 91
2019
Q2 		$555K Sell
1,966
-584
-23% -$160K 0.24% 106
2019
Q1 		$732K Sell
2,550
-144
-5% -$41.6K 0.32% 87
2018
Q4 		$708K Sell
2,694
-59
-2% -$16.2K 0.36% 75
2018
Q3 		$754K Buy
2,753
+470
+21% +$122K 0.29% 79
2018
Q2 		$543K Buy
2,283
+566
+33% +$131K 0.24% 86
2018
Q1 		$377K Buy
+1,717
New +$403K 0.18% 103

Other funds holding ELV

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
KBC Group
KBC Group Brussels, Belgium $39.9B AUM 29.7% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Cedar Capital's ELV Position: Q4 2020 in Review

Cedar Capital sold out of Elevance Health (ELV) in Q4 2020, closing a stake of 4,947 shares — an estimated $1.33M sold.

Cedar Capital first reported a position in ELV in Q1 2018 and held it in 11 quarters. The position peaked at $1.33M in Q3 2020. 1,170 funds tracked by Wall St. Rank hold ELV as of Q4 2020.

  • Cedar Capital reported no remaining Elevance Health position as of Q4 2020 after selling out during the quarter.
  • Cedar Capital sold 4,947 Elevance Health shares in Q4 2020, an estimated $1.33M.
  • Cedar Capital first reported a position in Elevance Health in Q1 2018 and held it in 11 quarters.
  • Cedar Capital's Elevance Health position peaked at $1.33M in Q3 2020.
  • 1,170 funds tracked by Wall St. Rank held Elevance Health as of Q4 2020.

Based on Cedar Capital's 13F filing for Q4 2020, filed 5 Feb 2021.